182 related articles for article (PubMed ID: 20578982)
1. New insights of CTLA-4 into its biological function in breast cancer.
Mao H; Zhang L; Yang Y; Zuo W; Bi Y; Gao W; Deng B; Sun J; Shao Q; Qu X
Curr Cancer Drug Targets; 2010 Nov; 10(7):728-36. PubMed ID: 20578982
[TBL] [Abstract][Full Text] [Related]
2. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
[TBL] [Abstract][Full Text] [Related]
3. [Expressions of Fas, CTLA-4 and RhoBTB2 genes in breast carcinoma and their relationship with clinicopathological factors].
Bi Y; Wei L; Mao HT; Zhang L; Zuo WS
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):749-53. PubMed ID: 19173804
[TBL] [Abstract][Full Text] [Related]
4. Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients.
Karabon L; Partyka A; Ciszak L; Pawlak-Adamska E; Tomkiewicz A; Bojarska-Junak A; Roliński J; Wołowiec D; Wrobel T; Frydecka I; Kosmaczewska A
J Immunol Res; 2020; 2020():6545921. PubMed ID: 32775467
[TBL] [Abstract][Full Text] [Related]
5. Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activity.
Toussirot E; Saas P; Deschamps M; Pouthier F; Perrot L; Perruche S; Chabod J; Tiberghien P; Wendling D
Arthritis Res Ther; 2009; 11(4):R101. PubMed ID: 19570209
[TBL] [Abstract][Full Text] [Related]
6. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
Chi PD; Li L; Fan YY; Wu CY
Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
[TBL] [Abstract][Full Text] [Related]
7. Expression of CTLA-4 in nonhuman primate lymphocytes and its use as a potential target for specific immunotoxin-mediated apoptosis: results of in vitro studies.
Palmisano GL; Tazzari PL; Cozzi E; Bolognesi A; Polito L; Seveso M; Ancona E; Ricci F; Conte R; Stirpe F; Ferrara GB; Pistillo MP
Clin Exp Immunol; 2004 Feb; 135(2):259-66. PubMed ID: 14738454
[TBL] [Abstract][Full Text] [Related]
8. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Regulatory T Cell-Related Markers (FOXP3, CTLA-4 and GITR) by Peripheral Blood Mononuclear Cells from Patients with Breast Cancer.
Khalife E; Khodadadi A; Talaeizadeh A; Rahimian L; Nemati M; Jafarzadeh A
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3019-3025. PubMed ID: 30484986
[TBL] [Abstract][Full Text] [Related]
10. Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma.
Matsuura K; Yamaguchi Y; Ueno H; Osaki A; Arihiro K; Toge T
Cancer; 2006 Mar; 106(6):1227-36. PubMed ID: 16475148
[TBL] [Abstract][Full Text] [Related]
11. Correlation of blood lymphocyte CTLA-4 (CD152) induction in Hodgkin's disease with proliferative activity, interleukin 2 and interferon-gamma production.
Kosmaczewska A; Frydecka I; Boćko D; Ciszak L; Teodorowska R
Br J Haematol; 2002 Jul; 118(1):202-9. PubMed ID: 12100149
[TBL] [Abstract][Full Text] [Related]
12. In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma.
Aarstad HH; Vintermyr OK; Ulvestad E; Kross K; Heimdal JH; Aarstad HJ
PLoS One; 2015; 10(6):e0129724. PubMed ID: 26079381
[TBL] [Abstract][Full Text] [Related]
13. Reduced CTLA-4 protein and messenger RNA expression in umbilical cord blood T lymphocytes.
Miller RE; Fayen JD; Mohammad SF; Stein K; Kadereit S; Woods KD; Sramkoski RM; Jacobberger JW; Templeton D; Shurin SB; Laughlin MJ
Exp Hematol; 2002 Jul; 30(7):738-44. PubMed ID: 12135671
[TBL] [Abstract][Full Text] [Related]
14. Association between the expression of IL-10 and T cell activation proteins loss in early breast cancer patients.
Llanes-Fernández L; Arango-Prado Mdel C; Alcocer-González JM; Guerra-Yi ME; Franco-Odio S; Camacho-Rodríguez R; Madrid-Marina V; Tamez-Guerra R; Rodríguez-Padilla C
J Cancer Res Clin Oncol; 2009 Feb; 135(2):255-64. PubMed ID: 18651178
[TBL] [Abstract][Full Text] [Related]
15. Insulin treatment in patients with type 1 diabetes induces upregulation of regulatory T-cell markers in peripheral blood mononuclear cells stimulated with insulin in vitro.
Tiittanen M; Huupponen JT; Knip M; Vaarala O
Diabetes; 2006 Dec; 55(12):3446-54. PubMed ID: 17130491
[TBL] [Abstract][Full Text] [Related]
16. A Study of Interleukin-2 Production and Nck Adaptor Molecule Gene Expression in Systemic Lupus Erythematosus Patients.
Towiwat P; Buttham B
J Med Assoc Thai; 2017 Apr; 100(4):396-402. PubMed ID: 29911835
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.
Liyanage UK; Moore TT; Joo HG; Tanaka Y; Herrmann V; Doherty G; Drebin JA; Strasberg SM; Eberlein TJ; Goedegebuure PS; Linehan DC
J Immunol; 2002 Sep; 169(5):2756-61. PubMed ID: 12193750
[TBL] [Abstract][Full Text] [Related]
18. Expression of CTLA-4 molecule in peripheral blood T lymphocytes from patients with systemic lupus erythematosus.
Liu MF; Liu HS; Wang CR; Lei HY
J Clin Immunol; 1998 Nov; 18(6):392-8. PubMed ID: 9857283
[TBL] [Abstract][Full Text] [Related]
19. Dual silencing of tumor-intrinsic VISTA and CTLA-4 stimulates T-cell mediated immune responses and inhibits MCF7 breast cancer development.
Hosseinkhani N; Hemmat N; Baghbani E; Baghbanzadeh A; Kazemi T; Mokhtarzadeh A; Jafarlou M; Amin Doustvandi M; Baradaran B
Gene; 2024 Feb; 896():148043. PubMed ID: 38042220
[TBL] [Abstract][Full Text] [Related]
20. The role of interleukin-6 in mitogenic T-cell activation: detection of interleukin-2 heteronuclear RNA by polymerase chain reaction.
Walz G; Stevens C; Zanker B; Melton LB; Clark SC; Suthanthiran M; Strom TB
Cell Immunol; 1991 May; 134(2):511-9. PubMed ID: 1827050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
